Lilly(Eli) & Co [NYSE: LLY] jumped around 0.39 points on Thursday, while shares priced at $780.16 at the close of the session, up 0.05%. The company report on March 7, 2024 at 8:00 AM that Lilly’s Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care.
Two new films draw attention to the importance of treating obesity as a disease and the appropriate use of anti-obesity medications.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eli Lilly and Company (NYSE: LLY) today launched the next phase of its Get Better corporate branding campaign with a new focus on obesity. Earlier this year, Lilly launched Get Better to reinforce its commitment to discovering and making medicines that give people a chance at better health.
Compared to the average trading volume of 3.26M shares, LLY reached a trading volume of 3940332 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Lilly[Eli] & Co [LLY]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LLY shares is $795.81 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LLY stock is a recommendation set at 1.79. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
DZ Bank have made an estimate for Lilly(Eli) & Co shares, keeping their opinion on the stock as Hold, with their previous recommendation back on February 21, 2024. While these analysts kept the previous recommendation, Morgan Stanley raised their target price from $805 to $950. The new note on the price target was released on February 16, 2024, representing the official price target for Lilly(Eli) & Co stock. Previously, the target price had yet another drop from $660 to $610, while Daiwa Securities kept a Outperform rating on LLY stock.
The Average True Range (ATR) for Lilly(Eli) & Co is set at 20.91, with the Price to Sales ratio for LLY stock in the period of the last 12 months amounting to 21.72. The Price to Book ratio for the last quarter was 68.76, with the Price to Cash per share for the same quarter was set at 3.08. Price to Free Cash Flow for LLY in the course of the last twelve months was 935.37 with Quick ratio for the last quarter at 0.73.
How has LLY stock performed recently?
Lilly(Eli) & Co [LLY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.51. With this latest performance, LLY shares gained by 10.66% in over the last four-week period, additionally plugging by 39.33% over the last 6 months – not to mention a rise of 151.15% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LLY stock in for the last two-week period is set at 66.42, with the RSI for the last a single of trading hit 63.50, and the three-weeks RSI is set at 67.70 for Lilly(Eli) & Co [LLY]. The present Moving Average for the last 50 days of trading for this stock 685.00, while it was recorded at 782.38 for the last single week of trading, and 568.15 for the last 200 days.
Lilly[Eli] & Co [LLY]: Deeper insight into the fundamentals
Lilly(Eli) & Co’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.73 and a Current Ratio set at 0.94.
Earnings analysis for Lilly(Eli) & Co [LLY]
With the latest financial reports released by the company, Lilly(Eli) & Co posted 1.62/share EPS, while the average EPS was predicted by analysts to be reported at 1.73/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -6.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LLY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Lilly(Eli) & Co go to 50.73%.
Insider trade positions for Lilly[Eli] & Co [LLY]
The top three institutional holders of LLY stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in LLY stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in LLY stock with ownership which is approximately 5.8325%.
